Antimicrobial resistance of Shigella spp. from humans in Shanghai, China, 2004-2011

Diagnostic Microbiology and Infectious Disease

Volumn 78, Issue 3, 2014, Pages 282-286

  Zhang, Jianmin ^a   Jin, Huiming ^b   Hu, Jiayu ^b   Yuan, Zhengan ^b   Shi, Weimin ^c   Yang, Xiaowei ^a   Xu, Xuebin ^b   Meng, Jianghong ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Shanghai Municipal Ke Ma Jia Technology Center for Microbiology   (China)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Antimicrobial resistance; Shigella

Indexed keywords

ANTIMICROBIAL RESISTANCE; SHIGELLA;

ADOLESCENT; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; FEMALE; FLUOROQUINOLONES; GENTAMICINS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROTYPING; SHIGELLA; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84893784327     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.11.023     Document Type: Article

References (32)

1. Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp. Antimicrob Agents Chemother 2003, 47:827-829.
2. Alici O., Acikgoz Z.C., Gamberzade S., Gocer S., Karahocagil M.K. Antibiotic resistance rates of Shigella species isolated from stool cultures in the years 1999-2003. Mikrobiyol Bul 2006, 40:9-14.
3. Bangtrakulnonth A., Vieira A.R., Lo Fo Wong D.M., Pornreongwong S., Pulsrikarn C., Sawanpanyalert P., et al. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Foodborne Pathog Dis 2008, 5:773-784.
4. Bardhan P., Faruque A.S., Naheed A., Sack D.A. Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerg Infect Dis 2010, 16:1718-1723.
5. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk Susceptibility Tests 2009, CLSI, Villanova, PA.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 20th informational supplement 2010, CLSI, Villanova, PA.
7. Ekdahl K., Andersson Y. The epidemiology of travel-associated shigellosis-regional risks, seasonality and serogroups. J Infect 2005, 51:222-229.
8. Filliol-Toutain I., Chiou C.S., Mammina C., Gerner-Smidt P., Thong K.L., Phung D.C., et al. Global distribution of Shigella sonnei clones. Emerg Infect Dis 2011, 17:1910-1912.
9. Gupta A., Polyak C.S., Bishop R.D., Sobel J., Mintz E.D. Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns. Clin Infect Dis 2004, 38:1372-1377.
10. Hoffman R.E., Shillam P.J. The use of hygiene, cohorting, and antimicrobial therapy to control an outbreak of shigellosis. Am J Dis Child 1990, 144:219-221.
11. Kim D.M., Neupane G.P., Jang S.J., Kim S.H., Lee B.K. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi. Int J Antimicrob Agents 2010, 36:155-158.
12. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999, 77:651-666.
13. Mamatha B., Pusapati B.R., Rituparna C. Changing patterns of antimicrobial susceptibility of Shigella serotypes isolated from children with acute diarrhea in Manipal, South India, a 5 year study. Southeast Asian J Trop Med Public Health 2007, 38:863-866.
14. Mates A., Eyny D., Philo S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995. Eur J Clin Microbiol Infect Dis 2000, 19:108-111.
15. Nataro J.P., Bopp C.A., Fields P.I., Kaper J.B., Strockbine N.A. Escherichia, Shigella, and Salmonella. Manual Clin Microbiol 2011, 603-626.
16. Niyogi S.K. Shigellosis. J Microbiol 2005, 43:133-143.
17. Opintan J., Newman M.J. Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates. Ghana Med J 2007, 41:8-29.
18. Ozmert E.N., Ince O.T., Orun E., Yalcin S., Yurdakok K., Gur D. Clinical characteristics and antibiotic resistance of Shigella gastroenteritis in Ankara, Turkey between 2003 and 2009, and comparison with previous reports. Int J Infect Dis 2011, 15:e849-e853.
19. Pryamukhina N.S., Khomenko N.A. Suggestion to supplement Shigella flexneri classification scheme with the subserovar Shigella flexneri 4c: phenotypic characteristics of strains. J Clin Microbiol 1988, 26:1147-1149.
20. Qiu S., Wang Z., Chen C., Liu N., Jia L., Liu W., et al. Emergence of a novel Shigella flexneri serotype 4 s strain that evolved from a serotype X variant in China. J Clin Microbiol 2011, 49:1148-1150.
21. Qu F., Bao C., Chen S., Cui E., Guo T., Wang H., et al. Genotypes and antimicrobial profiles of Shigella sonnei isolates from diarrheal patients circulating in Beijing between 2002 and 2007. Diagn Microbiol Infect Dis 2012, 74:166-170.
22. Salam M.A., Bennish M.L. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991, 13(Suppl 4):S332-S341.
23. Salmanzadeh-Ahrabi S., Jafari F., Habibi E., Irajian G.R., Aslani M.M., Baghbani-Arani F., et al. Serotype distribution and antimicrobial resistance rates of Shigella spp. isolates in Tehran, Iran. Mikrobiyol Bul 2007, 41:453-457.
24. Shiferaw B., Solghan S., Palmer A., Joyce K., Barzilay E.J., Krueger A., et al. Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2010. Clin Infect Dis 2012, 54(Suppl 5):S458-S463.
25. Sui J., Zhang J., Sun J., Chang Z., Zhang W., Wang Z. Surveillance of bacillary dysentery in China, 2009. Dis Surveill 2010, 25:947-950.
26. Vinh H., Nhu N.T., Nga T.V., Duy P.T., Campbell J.I., Hoang N.V., et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 2009, 9:204.
27. Vlieghe E., Phoba M.F., Tamfun J.J., Jacobs J. Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008. Int J Antimicrob Agents 2009, 34:295-303.
28. Vrints M., Mairiaux E., Van Meervenne E., Collard J.M., Bertrand S. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol 2009, 47:1379-1385.
29. Wang X.Y., Tao F., Xiao D., Lee H., Deen J., Gong J., et al. Trend and disease burden of bacillary dysentery in China (1991-2000). Bull World Health Organ 2006, 84:561-568.
30. World Health Organization (WHO). Guidelines for the Control of Shigellosis, Including Epidemics due to Shigella dysenteriae type 1. Geneva: Organization WH 2005.
31. Xia S., Xu B., Huang L., Zhao J.Y., Ran L., Zhang J., et al. Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. J Clin Microbiol 2011, 49:232-242.
32. Ye C., Lan R., Xia S., Zhang J., Sun Q., Zhang S., et al. Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri. J Clin Microbiol 2010, 48:419-426.